Lymphocytes and hematopoietic cells of the myelomonocytic lineage reciprocally interact during differentiation and in their roles as regulatory and effector cells of adaptive and non-adaptive immunity. Lymphocyte products, or lymphokines, are particularly important in regulating activation and function of phagocytic cells of the myelomonocytic lineage during immune response or inflammation. Lymphokines also have a regulatory role on proliferation, differentiation, and functional activity of cells of the myelomonocytic lineage at different stages of differentiation, from the precursor to the terminally differentiated cells. Although these effects have been determined in vitro or in vivo in pathologic situations, it is likely that the effects observed in pathology are an exaggeration of the physiologic role played by lymphocytes and their products in regulation of the homeostasis of the hematopoietic system. The long range objective of this project is to identify and investigate the mechanisms of interaction between lymphocytes and myelomonocytic cells. Part of our studies are performed using in vitro established human myeloid cell lines as a model system of differentiation in which regulation by lymphokines of differentiation-associated markers is analyzed at phenotypic and molecular levels. The study will be focused on the investigation of the molecular mechanisms by which tumor necrosis factor and interferon- gamma act synergistically in inducing monocytic differentiation in immature myeloid cells. The modulating effects of other lymphokines will also by analyzed. Among other markers of differentiation, the maturation of the NADPH oxidase system and respiratory burst capabilities during normal and lymphokine-induced myelomonocytic cell differentiation will be investigated. The information obtained in these model systems is then applied to the study of normal and leukemic cells, in order to understand how differentiation and maturation are regulated in physiologic conditions and their alteration in malignant myelomonocytic cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032898-11
Application #
3170779
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1982-08-01
Project End
1995-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
11
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Grazia Cappiello, M; Sutterwala, F S; Trinchieri, G et al. (2001) Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol 166:4498-506
Geng, Y; Berencsi, K; Gyulai, Z et al. (2000) Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun 68:2245-53
Geng, Y; Shane, R B; Berencsi, K et al. (2000) Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 164:5522-9
Peritt, D; Sesok-Pizzini, D A; Schretzenmair, R et al. (1999) C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease. J Immunol 162:7563-8
Trinchieri, G; Scott, P (1999) Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238:57-78
Fox, F E; Kubin, M; Cassin, M et al. (1999) Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Cytokine Res 19:407-15
Ma, X; Riemann, H; Gri, G et al. (1998) Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 9:54-64
Schwarz, A; Grabbe, S; Mahnke, K et al. (1998) Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells. J Invest Dermatol 110:272-6
Schwarz, A; Grabbe, S; Grosse-Heitmeyer, K et al. (1998) Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J Immunol 160:4262-70
Gri, G; Savio, D; Trinchieri, G et al. (1998) Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J Biol Chem 273:6431-8

Showing the most recent 10 out of 83 publications